首页 | 本学科首页   官方微博 | 高级检索  
检索        

新型药物Salazotyrin对类风湿性关节炎患者的疗效观察
引用本文:宁建新.新型药物Salazotyrin对类风湿性关节炎患者的疗效观察[J].中国现代医生,2011,49(16):49-50.
作者姓名:宁建新
作者单位:浙江省江山市中医院骨科,浙江江山,424100
摘    要:目的观察肿瘤坏死因子抑制剂Salazotyrin治疗类风湿性关节炎(rheumatoid arthritis,RA)的治疗效果及对人体的安全性。方法97例RA患者随机分为两组,对照组57例给予传统药物氨甲蝶呤和硫酸羟氯喹;治疗组40例应用Salazotyrin进行为期3个月的治疗。结果治疗组总有效率(92.5%)显著高于对照组(71.9%)(P〈0.05),在关节肿胀数、关节肿胀指数、晨僵时间和关节压痛指数等方面均与用药前有显著差异(P〈0.05),且该药与传统药物所产生的副反应无显著差异。结论Salazotyrin治疗RA疗效明显优于传统的氨甲蝶呤和硫酸羟氯喹,且不良反应少而轻微,安全性好。

关 键 词:类风湿性关节炎  Salazotyrin  抑制剂

Clinical Study of Rheumatoid Arthritis Treated by A New Drug Salazotyrin
Authors:NING Jianxin
Institution:NING Jianxin Department of Drthopaedics,Zhejiang Province Jiangshan Traditional Chinese Medicine Hospital,Jiangshan 424100,China
Abstract:Objective To observe the effectiveness and safety in the treatment of rheumatoid arthritis(RA) with a antagonist for tumor necrosis factor,Salazotyrin.Methods We randomly divided 97 RA patients into 2 groups:the control group(57 RA patients) was given hydroxychloroquine and methotrexate sulfuric acid for 3 months;the treatment group(40 patients) was treated by Salazotyrin for the same period.Results The total effectiveness rate of the treatment group(92.5%) was significantly higher than that of control grou...
Keywords:Rheumatoid arthritis  Salazotyrin  Antagonist  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号